http://www.feedburner.comInstitute of Medicine RSS feed for the following topic: Biomedical and Health ResearchTremendous variability in wait times for health care appointments exists throughout the U.S., ranging from same day service to several months, says a new report from the Institute of Medicine.http://www.iom.edu/Reports/2015/Transforming-Health-Care-Scheduling-and-Access/Getting-To-Now-Media-Advisory.aspx6/29/2015The Institute of Medicine (IOM) report Crossing the Quality Chasm identified six fundamental aims for health care—that it be safe, effective, patient-centered, efficient, equitable, and timely. Of these fundamental aims, timeliness is in some ways the least well studied and understood. How can timely care be ensured in various health care settings, and what are some of the reasons that care is sometimes not timely? The report presented here was developed by the IOM Committee on Optimizing Scheduling in Health Care to answer such questions. http://www.iom.edu/Reports/2015/Transforming-Health-Care-Scheduling-and-Access.aspx6/29/2015The first of a series of three workshops, this workshop will be aimed at advancing the understanding of effective approaches in managing the care of high-need patients, drawing attention to opportunities to improve outcomes and reduce the costs of health care for these vulnerable populations.http://www.iom.edu/Activities/Quality/VSRT/2015-JUL-07.aspx6/26/2015The National Academy of Medicine’s Annual Meeting (October 19, 2015) on Aging: Complexities, Opportunities, And Impacts on Society will explore this topic from a variety of perspectives and should make for a lively and worthwhile exchange.http://www.iom.edu/Activities/PublicHealth/AnnualMeeting/2015-OCT-19.aspx6/25/2015The Institute of Medicine Roundtable on Translating Genomic-Based Research for Health brings together leaders from academia, industry, government, foundations and associations who have a mutual interest in addressing the issues surrounding the translation of genomic-based research. The mission of the Roundtable is to advance the field of genomics and improve the translation of research findings to health care, education, and policy. http://www.iom.edu/Activities/Research/GenomicBasedResearch.aspx6/25/2015Biological differences between the sexes influence not only individual health but also public health, biomedical research, and health care. The IOM held a workshop March 8-9, 2010, to discuss sex differences and their implications for translational neuroscience research, which bridges the gap between scientific discovery and application.http://www.iom.edu/Reports/2010/Sex-Differences-and-Implications-for-Translational-Neuroscience-Research.aspx6/24/2015Millions of people in sub-Saharan Africa suffer from mental, neurological, and substance use (MNS) disorders, and most do not have the resources to obtain treatment. The Uganda National Academy of Sciences and the IOM hosted a workshop to discuss the state of care for MNS disorders in sub-Saharan Africa.http://www.iom.edu/Reports/2010/Mental-Neurological-and-Substance-Use-Disorders-in-Sub-Saharan-Africa-Reducing-the-Treatment-Gap-Increasing-Quality-of-Care.aspx6/24/2015Problems with how the neurotransmitter glutamate functions in the brain have been linked to a wide variety of disorders, including schizophrenia, Alzheimer’s, substance abuse, and traumatic brain injury. Efforts to understand, treat, and prevent glutamate-related disorders can be aided by the identification of valid biomarkers. The IOM’s Forum on Neuroscience and Nervous System Disorders held a workshop June 21-22, 2010, to explore ways to accelerate the development, validation, and implementation of such biomarkers.http://www.iom.edu/Reports/2011/Glutamate-Related-Biomarkers-in-Drug-Development-for-Disorders-of-the-Nervous-System.aspx6/24/2015The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system—including psychiatric drugs—are assessed for whether that drug might cause suicidal ideation or behavior. The IOM’s Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA’s new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future.http://www.iom.edu/Reports/2010/CNS-Clinical-Trials-Suicidality-and-Data-Collection.aspx6/24/2015Presentation at the Alzheimer's Association International Conference on Alzheimer's Disease 2011 http://www.iom.edu/Activities/Research/NeuroForum/2011-JUL-18.aspx6/24/2015The goal of the workshop was to present promising current and emerging technologies with potential as reliable glutamate biomarkers, and to outline strategies to accelerate development, validation, and implementation of these biomarkers as powerful tools to advance drug development for nervous system disorders associated with glutamatergic dysfunction.http://www.iom.edu/Activities/Research/NeuroForum/2010-JUN-21.aspx6/24/20152015 Meeting of the Committee to Review NASA's Evidence Reportshttp://www.iom.edu/Activities/Research/NASAEvidenceReports/2015-JUN-22.aspx6/24/2015The workshop brought together key stakeholders to assess the current state of the quality of care for neurological, mental, and substance use disorders in sub-Saharan Africa.http://www.iom.edu/Activities/Research/NeuroForum/2009-AUG-04.aspx6/24/2015This IOM workshop will examine the clinical benefits and comparative effectiveness of emerging advanced technologies for cancer treatment in radiation therapy and surgery. Workshop participants will discuss current utilization patterns, with a focus on diffusion of new technologies into oncology practice, as well as evidence on the overuse, underuse, and misuse of these technologies, and potential strategies to assess the value and define optimal use of new technologies in cancer treatment.http://www.iom.edu/Activities/Disease/NCPF/2015-JUL-20.aspx6/23/2015Many voluntary health organizations fund translational research. An increasing number of these organizations are looking at venture philanthropy as a critical way to advance their missions of helping patients and working to cure disease. A wide range of participants gathered on October 3, 2008 at the Beckman Center of the National Academies of Science for a workshop titled “Venture Philanthropy Strategies Used by Patient Organizations to Support Translational Research.” Participants with experience in venture philanthropy shared their experiences and lessons learned in order to improve efficiency and effectiveness in translational research.http://www.iom.edu/Reports/2009/Venture-Philanthropy-Strategies-to-Support-Translational-Research-Workshop-Summary.aspx6/23/2015On June 25, 2008, the IOM Forum on Neuroscience and Nervous System Disorders hosted more than 70 of the leading neuroscientists in the world, for a workshop titled From Molecules to Minds: Challenges for the 21st Century. The objective of the workshop was to explore a set of common goals or “Grand Challenges” posed by participants that could inspire and rally both the scientific community and the public to consider the possibilities for neuroscience in the 21st century.http://www.iom.edu/Reports/2008/From-Molecules-to-Minds-Challenges-for-the-21st-Century.aspx6/23/2015The workshop brought together experts from multiple areas to discuss the most promising and practical arenas in neuroscience in which biomarkers will have the greatest impact. The main objective of the workshop was to identify and discuss biomarker targets that are not currently being aggressively pursued but that could have the greatest near-term impact on the rate at which new treatments are brought forward for psychiatric and neurological disorders.http://www.iom.edu/Reports/2008/Neuroscience-Biomarkers-and-Biosignatures-Converging-Technologies-Emerging-Partnerships.aspx6/22/2015On April 18 and 19, 2007, the Institute of Medicine’s (IOM’s) Forum on Neuroscience and Nervous System Disorders, in response to a request from the U.S. Secretary of Health and Human Services, hosted a workshop called “Autism and the Environment: Challenges and Opportunities for Research.” The goal of the workshop was to provide a venue to bring together scientists, members of the autism community, and the major sponsors of autism-related research to discuss the most promising scientific opportunities. http://www.iom.edu/Reports/2007/Autism-and-the-Environment-Challenges-and-Opportunities-for-Research-Workshop-Proceedings.aspx6/22/2015Combination unit respirators, a respirator that employs the technology of two or more types of respiratory protection, are presently used in the United States by some law enforcement and military units to respond to situations in which there are unknown and potentially dangerous respiratory hazards; they also have some industrial uses and potential for use in emergency response.http://www.iom.edu/Reports/2015/Developing-a-Performance-Standard-for-Combination-Unit-Respirators-WIB.aspx6/17/2015The IOM Forum on Neuroscience and Nervous System Disorders is hosting a session at the 2015 AAIC, titled "Assessing the Impact of Applications of Digital Health Records."http://www.iom.edu/Activities/Research/NeuroForum/2015-JUL-20.aspx6/16/2015This workshop, hosted by the National Cancer Policy Forum, will examine the rationale and potential for integrating clinical trials for pets with naturally occurring cancers into translational cancer research and development. It will also highlight potential opportunities to overcome existing challenges.http://www.iom.edu/Activities/Disease/NCPF/2015-JUN-08.aspx6/10/2015The first workshop in a two-part series on cancer care in low resource areas. The first workshop will focus on cancer prevention and early detection.http://www.iom.edu/Activities/Disease/NCPF/2015-OCT-26.aspx6/5/2015The current epidemic of Ebola Virus Disease (EVD), cause by a filovirus, has spread internationally, now affecting multiple continents, and has become the worst EVD outbreak in history since its discovery in 1976. While the Ebola viruses have typically been studied in laboratory settings, additional biomedical and public health research in real world settings can best prepare the United States to safeguard the public and at-risk workers.http://www.iom.edu/Reports/2014/Research-Priorities-to-Inform-Public-Health-and-Medical-Practice-for-Ebola-Virus-Disease-WIB.aspx6/3/2015The IOM Roundtable on Value & Science-Driven Health Care convenes leadership from key healthcare sectors to catalyze the collaborative work needed to drive improvements in the effectiveness and efficiency of medical care, by transforming how evidence is developed and used in health care.http://www.iom.edu/Activities/Quality/VSRT.aspx6/1/2015The third meeting of the Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies will take place on June 11-12 in Room 106 of the Keck Center in Washington, DC. The open session will begin at 9:00 am and adjourn at 11:30 am on June 11 and will be conducted exclusively via WebEx. The meeting will be closed in its entirety on June 12. If you wish to call in, please register through this page.http://www.iom.edu/Activities/Research/BiomarkersforMolecularlyTargetedTherapies/2015-JUN-11.aspx5/28/2015The IOM's Forum on Neuroscience and Nervous System Disorders focuses on building partnerships to further understand the brain and nervous system, disorders in their structure and function, as well as effective clinical prevention and treatment strategies.http://www.iom.edu/Activities/Research/NeuroForum.aspx5/27/2015More than 1.2 billion people worldwide play video games (online, via console, mobile phone, and other wireless devices), and many may be unaware that programmers often incorporate neuroscience into game design. Given the high prevalence of gaming in today’s society, the Institute of Medicine (IOM) Forum on Neuroscience and Nervous System Disorders hosted the Social Issues Roundtable at the Society for Neuroscience annual meeting on November 16, 2014, in Washington, DC, to explore the neuroscience of video games, with emphasis on relevant scientific, ethical,and societal issues.http://www.iom.edu/Reports/2015/Neuroscience-Gaming-WIB.aspx5/26/2015The Institute of Medicine’s Forum on Medical and Public Health Preparedness for Catastrophic Events serves to foster dialogue among stakeholders and provide ongoing opportunities to discuss and confront issues of mutual interest and concern. More specifically, the Forum: provides a catalyst for voluntary public/private collaboration on topics where there is synergy among potential partners; helps define the scope of the field and thus sets the stage for future policy action; brings ongoing attention and visibility to important preparedness issues; explores new approaches for resolving problem areas; and elevates the general understanding and visibility of medical and public health preparedness in the broader research, public policy, and other appropriate communities. http://www.iom.edu/Activities/PublicHealth/MedPrep.aspx5/20/2015This workshop, hosted by the Forum on Medical and Public Health Preparedness for Catastrophic Events, the Forum on Drug Discovery, Development, and Translation, and the Forum on Microbial Threats will bring together public and private stakeholders to discuss how to achieve rapid and nimble medical countermeasure development for new and emerging threats. Discussions will include real-world case studies to elucidate how past events were handled from a policy, budget, and operational standpoint, and contribute to a better aggregate picture of how future “worst case scenarios” might unfold. This workshop will examine principles that either enable or challenge strong public/private partnerships and consider the needs of the private sector to successfully ramp up research, development, and production in a rapid and nimble manner once a threat warrants the need.http://www.iom.edu/Activities/PublicHealth/MedPrep/2015-MAR-26.aspx5/18/2015To examine pragmatic approaches to incorporating genomics in learning health care systems, the IOM’s Roundtable on Translating Genomic-Based Research for Health hosted a workshop on December 8, 2014. A variety of stakeholder groups, including commercial developers, health information technology professionals, clinical providers, academic researchers, patient groups, and government and health system representatives, presented their perspectives and participated in discussions on maximizing the value that can be obtained from genomic information. The workshop examined how a variety of systems are capturing and making use of genomic data to generate knowledge for advancing health care in the 21st century. It also sought to evaluate the challenges, opportunities, and best practices for capturing or using genomic information in knowledge-generating health care systems.http://www.iom.edu/Reports/2015/Genomic-Enabled-Learning-Health-Care-Systems.aspx5/15/2015